Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02234986
Title A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CASI Pharmaceuticals, Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.